European Archives - Page 49 of 1203 - European Medical Journal

Psoriasis Severity Strongly Linked to Metabolic Syndrome

The bidirectional relationship between psoriasis and MetS was supported by evidence showing that metabolic disturbances can also exacerbate psoriasis symptoms.

Breaking Barriers in Lung Cancer: Precision in Staging and Surgery

In the third episode of our lung cancer miniseries, Jonathan Sackier is joined by Douglas E. Wood to explore the critical role of lung cancer staging, the evolution of screening guidelines, and more.

Erratum: Advancements in Hydrogel-Based Therapies as Non-surgical Alternatives for Urothelial Carcinoma: Ongoing Research and New Insights

Psychiatric Symptoms Largely Overlooked in Urology Trials

Insomnia appeared in 61%, cognitive impairment and irritability in 38%, and more severe psychiatric issues such as psychosis and delirium were rarely considered.

Lennard Lee

Onc Now: Episode 20: How Cancer Vaccines Are Changing Medicine

Lennard Lee, Associate Professor of Cancer Vaccines at the University of Oxford, shares how large-scale collaboration is shaping the future of cancer vaccines and oncology innovation.

Genomic Sequencing Identifies Novel Genetic Loci in Spontaneous Pneumothorax

A genome-wide association study reveals four novel loci linked to primary spontaneous pneumothorax, identifying CBX7-mediated matrix dysregulation as a key pathogenic mechanism.

CEM After DBT Detects Hidden Cancers Missed by Standard Screening

Learn how CEM after DBT detects more early cancers in high-risk women, though with higher false positive rates.

Stem Cell Therapy Zimislecel Shows Promise in Type 1 Diabetes

Discover how zimislecel enables insulin independence in patients with Type 1 diabetes, showing strong efficacy in early clinical data.

Philips’ Dr Carla Goulart Peron on AI, equity and the future of care

How can AI expand healthcare access without losing the human touch? Philips’ CMO Dr Carla Goulart Peron shares all.

NICE Turns Down Breakthrough Drugs for Patients with Alzheimer’s

Despite the setback, hope remains, with 138 dementia drugs currently in trials, experts say more effective, safer options may soon emerge.